Two whistleblowers came forward in April to accuse Questcor of trying to boost profits for Acthar, a medication primarily for infants with seizures. Questcor raised the price of the medication by almost 100,000 percent (not a typo) from just $40 in 2000 to $38,892 today, despite the fact that Acthar has been on the market since 1952. Mallinckrodt currently rakes in about $1 billion per year from Acthar, according to CNN.
Today, in Medicare-For-All-is-inevitable news: One company jacked up the price of a drug for newborns from $40 to FORTY THOUSAND DOLLARS, even though it has been around since 1952, and THEN they were caught bribing doctors to prescribe it!
There’s only so much of this our system can take before enough people get affected by it and vote for a nationalized health care system — despite whatever negatives they might fear — because surely nothing can be as bad as what they’re dealing with.